Keyword results: Advanced Oncotherapy

AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – First LIGHT System Delayed: Oopsadaisie……Still a Sell

Well surprise, surprise! AIM-listed Advanced Oncotherapy (AVO) has announced that the first fully operational LIGHT system has been delayed from the end of this year to the end of Q1 next year. I noted HERE that the delay announced this morning was pretty well baked in. Given that we have moved from “could slip into Q1 2022” to “around the end of Q1 2022” in the space of less than two and a half months, it seems to me that further slippage is highly likely. Indeed, despite this morning’s announcement, one wonders whether any progress has been made at all since the announcement of diabolical interims at the end of September. So there will be at least another quarter sans revenue……what about the cash?

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – Diabolical Interims as Market is Softened up for Delay to First Operational LIGHT System

Oh dear, oh dear, oh dear. AIM-listed Advanced Oncotherapy has announced its interims to June: the numbers are predictably dreadful but the killer is surely the indication of a delay to the completion of the company’s first proton therapy LIGHT system.

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – Delayed Subscription Proceeds, Uh-Oh……

AIM-listed Advanced Oncotherapy (AVO) announced yesterday, Friday 3rd September, that funds due in to settle the subscription announced back on 11th August would not be arriving in full for up to an additional two weeks. Yet on 31 August – just three days previously – the subscription shares were due to be issued on Friday. Hmm.

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

BREAKING: Red Flags at Night: Advanced Oncotherapy Warrant Conversion is this an illegitimate free £75,000 for someone?

Here is an odd thing: last night, after hours at 4.48pm, AIM-listed Advanced Oncotherapy (AVO) announced that someone had issued an exercise notice in respect of 500,000 warrants issued back in July 2017 to subscribe for ordinary shares at 25p. Application to admit the shares has been made and admission is expected on or around August 20th. So what, you might ask. And that brings me to Advanced’s Annual Report for FY20.

Subscribe to ShareProphets to access Premium Content

Who is Supply@ME Capital’s death spiral provider – a series of remarkable coincidences

Who is Negma the death spiral provider to the fraud Supply@ME Capital (SYME). Negma probably thinks all its Christmas have come at once and cannot believe its luck being able to flog so many shares onto moronic mug punters thanks to a recent, utterly unjustified, rally? Well here are a series of remarkable coincidences for you to consider.

AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy - £40m Fundraise, Biggest to Date. So it is a Buy? Er…..

AIM-listed protons beams for cancer outfit Advanced Oncotherapy (AVO) announced a proposed £40 million fundraise yesterday – the largest to date – at 40p per share, a 17% premium to its average closing price over the past month, and a 13% premium to the previous close. I have to hand it to the company, that’s a great effort. But does it make the shares a buy?

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy Rattles the Tin Once Again – This time for a £6m fundraise

When I last wrote about AIM-listed Advanced Oncotherapy, at the end of October last year, it had just announced a placing at 30p per share to raise £7.7 million and my back-of-a-fag-packet suggested that despite the new money, it was placing ahoy. Well, yesterday that placing duly arrived with £6 million raised at a rather more impressive 40p. So will this be the last time the company passes round the hat? 

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – Fundraise at 30p (apparently a 13% discount). Tell the truth!

AIM-listed Advanced Oncotherapy (AVO) has announced a fundraise at 30p to raise £7.7 million (before expenses) – as predicted HERE by yours truly. Time for another glass of Ouzo, methinks.

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – Is it Placing Ahoy, and look what the cat dragged in!

I see that AIM-listed Advanced Oncotherapy (AVO) has appointed a new joint broker, in the form of SI Capital Ltd. Normally for an AIM-listed company surely one broker would be enough – unless someone wants to rattle the tin.

  • 497 days ago
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – Draws down on Convertible Loan. Is it a Death Spiral or what’s the catch?

It was announced this morning that AIM-listed Advanced Oncotherapy (AVO) has drawn down an initial $10 million on its secured convertible loan package totalling $30 million with Nerano Pharm – a financing vehicle wholly owned by significant shareholder Seamus Mulligan. So is this a death spiral, and what’s the catch?

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – surely a statement is needed: is it bust yet?

I cannot help but notice that shares in AIM-listed Advanced Oncotherapy (AVO) have fallen below their par value of 25p. For some companies this would present a bit of an embarrassment but for cash-guzzling AIM Casino plays with zero income it is surely a disaster. Since it's hard to see how a GM could be called in the current environment, will Advanced simply run out of (other peoples’) cash? And then there is the small matter of construction at Harley Street, which must be a tad tricky at the moment. On 20th February I noted the following:

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – good news, so why are the shares down 6.4%?

I suspect that ShareProphets readers already know the answer: that the news is really not all that great and thus it looks like a ramparoonie of the first order! Surely it could not be placing ahoy, could it?

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Letter to Nomad Allenby & AIM Regulation: Has Advanced Oncotherapy not told us something?

Nigel Somerville is too nice a guy to ask if a company has been a very naughty boy indeed. I am not.  I note his piece earlier on Advanced Oncotherapy (AVO) and it seems obvious that, while Nomad Allenby probably does not give a flying feck, the question should be asked. And so I have written to the Oxymorons at AIM Regulation asking them to investigate

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – classy polishing of a t***?

AIM-listed jam-tomorrow cancer treatment purveyor Advanced Oncotherapy (AVO) announced yesterday that it had signed up The London Clinic to run its Harley Street clinic proton therapy centre which is under construction. Well, sort of: the deal had reached a Memorandum of Understanding. This is course good news – except that it had already signed up Circle Health to run operations, and I fancy the real reason for yesterday’s RNS was revealed in CEO Nicholas Serandour’s comment where he reveals that the previous deal with Circle Health has lapsed. I wonder when Circle walked……

Subscribe to ShareProphets to access Premium Content
VRS
VRS
PREMIUM CONTENT

If you want to stop babies dying you need to back Versarien... Ricketts on twitter drivel

At the Woodford Patient Capital Trust (WPCT) AGM this year that scallywag Neil Woodford suggested that if I had any interest in beating the disease that would incdeed kill my dear Uncle Chris within weeks, that is to say cancer, I should be getting behind the joke company Rutherford Internationbal (RUTH) into which he had spunked vast amounts of other folks cash. This is a common meme among shameless promoters.

Subscribe to ShareProphets to access Premium Content
AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – fundraise via equity and debt ( bit more needed by Christmas, headline misleads)

AIM-listed Advanced Oncotherapy (AVO) announced a fundraise on Wednesday – great news! Or is it? I wonder how much cash it will actually have when all the money comes in – and why, AFTER the fundraise, did researcher-for-hire Hardman produce a report telling us all what a bargain the company is? Then there are loan and outstanding salary conversions and the total – £18.4 million – is still short of a year’s spending, and won’t all arrive until the end of September. It looks a bit desperate – especially when the loan to top up the equity raise will cost up to 15% a year in interest.

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast - my apologies for teasing Malcolm Stacey on ethical investment, I am a partial convert

I start with a few notes on  tomorrow, logistics and the funeral of Uncle Chris Booker. Then it is onto Yourgene (YGEN), Thomas Cook (TCG), Advanced Oncotherapy (AVO), Amur Minerals (AMC), and the dog St James House (SJH) formerly known as the Boxhill hound.

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: 2 stocks I own, mega bullish on one, mega bearish on the other - guess which?

In today;s bearcast I discuss Alpha Growth (ALGW), Advanced Oncotherapy (AVO) and Optibiotix (OPTI) as well as Spain, the latest crisis in the special place in hell that is the EU.

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – who’s been selling? Tut, tut!

AIM-listed Advanced Oncotherapy (AVO) announced director and significant shareholdings this morning, following its latest fundraising in December and resulting share issues yesterday. But it seems that one of the directors has been – undisclosed – selling!

AVO
AVO

Advanced Oncotherapy – when’s the placing?

Shares in AIM-listed Advanced Oncotherapy are up by 30% today on the back of yet another technological update and a Flash Note from its paid-for research ramper-in-chief GPSL, the second in less than a week. Of course, yesterday the shares were down by around the same amount which all leaves me wondering when’s the placing?

AVO
AVO
PREMIUM CONTENT

Advanced Oncotherapy – FY17 numbers, cash comes in but still to need a fundraising

AIM-listed Advanced Oncotherapy (AVO) released its FY17 numbers this morning. Looking through the numbers presented it is clear that the company was running on fumes last December. We are told that the company is in a stronger financial position since 31st December 2017 having secured £33.3m of financing post period end, but I wonder how much stronger?

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – hands up who knew Bracknor still had death spiral loan notes!

AIM-listed Advanced Oncotherapy (AVO) announced this morning that Bracknor, the death spiral funder, still had convertible loan notes to swap for shares. This, despite the RNS of 19 July 2017 telling us that the Company does not intend to use the Bracknor facility in the future. As part of these arrangements the Company will issue 7 million warrants to Bracknor. These warrants are exercisable at 25p and may be exercised at any time over the next five years. Anyone would have thought that was the end of the matter. Apparently not.

AVO
AVO

Advanced Oncotherapy – lies about Blackfinch deal, what are the finances like?

AIM-listed Advanced Oncotherapy finally got around to updating the market over its Blackfinch loan which matured on 24 March and was secured on its Harley Street premises. But it seems that the company can’t tell the truth!

Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: It is not just Stormy Daniels that Donald Trump has screwed - step forward ex Tory MP Tony Baldry and Westminster Group

I start with the latest developments on Julie Meyer and hint at what is coming next from myself and also from John Galt. Julie you ain't seen nothing yet. Praise be the Lord.  Then it is onto Westminster Group (WSG) and someone almost as loathsome as Meyer, that is to say ex Tory MP fat Tony Baldry. Then I look at Eden Reseearch (EDEN) which fat Tone knows well, Pantheon Resources (PANR), Advanced Oncotherapy (AVO), the tossers at the FT, Jubilee Metals (JLP) and other Beuafort Securities victims and Interserve (IRV) and the tools at the FCA.

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – UK site agreement, but what of the Blackfinch loan?

As we know from AIM-listed UK Oil and Gas (UKOG), the best thing to do when faced with an awkward question is to move the goal posts. And so this morning we see AIM-listed Advanced Oncotherapy (AVO), rather than ‘fess up over its overdue loan from Blackfinch which is secured on its Harley Street premises, telling us that it has signed a lease with the UK Government’s Science and Technology Facilities Council to establish a UK testing site for its LIGHT (proton therapy technology) system. I wonder what Advanced is going to pay with!

Bear
PREMIUM CONTENT

UK Investor Show Video 2018 The Bears session Lucian Miers, Matt Earl, Tom Winnifrith & Nigel Somerville

And the next video is the bears with myself, the Dark Destroyer Matt Earl, the Bard of the Boleyn Lucian Miers and a cameo by Nigel Somerville on Advanced Oncotherapy (AVO). On the agenda Telit (TCM), Tesla (TSLA), Mitie (MTO), IQE (IQE), RM2 (RM2),Avanti Communications (AVN), AIQ (AIQ) and a good stack more.

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast - The Fat Lady arrives at Nighthawk and Dave Whitby's payoff question

In the main bearcast of the day I start by asking what payoff disgraced Dave Whitby got at worthless insolvent POS Andalas (ADL)? And were mugs who backed the latest placing told where much of their cash was going ( i.e. to Whitby). Feel free to contact me if you are an Andalas owning mug. The fat Lady arrives at Nighthawk (HAWK) and looks to be in the wings at Nature Group (NGR) while new problems emerge at Imaginatik (IMTK) - a former Rob Terry fave but I speculate on bigger worries that the Quindell fraudster faces - and at Management Consulting (MMC). I think the fat Lady may well also have an appointment with Widecells Group ( WDC) shortly. I comment on 4 reasons why Advanced Oncotherapy (AVO) shares may be falling and on looming results at Optibiotix (OPTI), where we own shares.

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – now we know why the shares are up: prostitution pays!

So after my piece HERE wondering why AIM-listed Advanced Oncotherapy (AVO) was up 20-odd per cent it turns out that a research note was put out on the RNS system. The research note was from an outfit called Goetzpartners Securities Limited, which claims to be a leading pan-European investment bank and research firm. Right…. So who paid for this research, and is it worth the paper it is written on?

AVO
AVO

Advanced Oncotherapy - no response to my questions but shares rocket 22% today. Why?

As yet AIM-listed Advanced Oncotherapy (AVO) is yet to answer my questions about the Blackfinch loan which is secured on its Harley Street premises and which was due to expire back on 24 March. It has also ignored my questions about the Chinese funding from Yantai Cipu as to whether any funds  have actually arrived with Advanced. These two questions seem to me to be pertinent to Advanced's very survival, but all we have had is a wall of silence. You would have thought the market would get jittery, but out of the blue today its shares are up a whopping 22% (last seen).

AVO
AVO

Advanced Oncotherapy: …and now for the eleventh time!

Yet another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again – now for the eleventh time. They are serious questions and with the wrong answers I would struggle to see how the company is solvent. But Advanced continues to ignore the questions. So here we go again….

AVO
AVO

Advanced Oncotherapy: …and now for the tenth time!

And so yet another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again – now for the tenth time as we head into double figures.

AVO
AVO

Advanced Oncotherapy: …and now for the ninth time!

Yet another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again – now for the ninth time…..here we go again:

AVO
AVO

Advanced Oncotherapy: …and now for the eighth time!

Yet another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again – now for the seventh time. At this rate Jeremy Paxman’s score of 12 (against Michael Howard) is in danger. I have had it pointed out to me that Paxo asked the questions face to face, and in that regard I can’t match him. But at least (now) Lord Howard had to reply – even if he evaded the actual question. Anyway, here we go again:

AVO
AVO

Advanced Oncotherapy - for the seventh time!

Yet another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again – now for the seventh time. At this rate Jeremy Paxman’s score of 12 (against Michael Howard) is in danger.

AVO
AVO

Advanced Oncotherapy: …and for the sixth time

Another day passes and still AIM-listed Advanced Oncotherapy (AVO) has not answered my questions, and so I ask again. What is happening with the Blackfinch loan which had a 12 month term starting on 24 March last year, a loan which was secured on the company’s Harley Street premises? And has the company actually received any cash at all from its white knight saviour Yantai Cipu in China?

AVO
AVO

Advanced Oncotherapy – asking for the fifth time, and another question

This really is getting a bore. For the fifth time, I ask what is happening with the Blackfinch loan which had a 12 month term starting on 24 March last year, a loan which was secured on AIM-listed Advanced Oncotherapy’s (AVO) Harley Street premises. And for a fifth time I am asking if the company has actually received any cash at all from its white knight saviour Yantai Cipu in China. But first, there is a question raised by Drunken Sailor.

Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: 'fessing up to what the Mrs and I were up to last night & the deafening silence at Advanced Onco and Frontera

Ok this is embarassing but I will admit on tape what we were up to. It is our guilty pleasure and involves Deacon, Scarlett, Gunner, Avery and Will Lexington.  Then I look at WPP (WPP) and the deeply unsatisfactory and unfair way Sir Martin Sorrell has "resigned" - this smells all wrong. Finally I look at why Advanced Oncotherapy (AVO) and Frontera (FRR) are not answering or evading questions - it is because they are both bad companies. If you like bearcasts then remember that at UK Investor on April 21 one of many highlights will be a live bearcast with myself and Paul Scott. Make sure you book a free ticket HERE using the promotional code WINNIFRITH.

Subscribe to ShareProphets to access Premium Content
AVO
AVO

Advanced Oncotherapy – first mover in the UK? Er….

My thanks to two eagle-eyed ShareProphets readers who have posted in the comments sections of my pieces asking about AIM-listed Advanced Oncotherapy (AVO) and its funding from Yantai Cipu in China, and the now expired, secured (on Advanced’s Harley Street premises), Blackfinch loan. We’ve still not heard a thing about either which is rapidly drawing me to a conclusion as to the answers. Not to worry: I’ll ask (for the fourth time) again tomorrow. But, with big hat-tips to Drunken Sailor and Daniel Victor, it seems that Advanced isn’t even getting over the line at Harley Street before two other proton therapy centres (one of which is up and running already) come on stream. It seems that first mover advantage has already been lost.

AVO
AVO

Advanced Oncotherapy – still no answer to my questions, but does the market know something I don’t?

I have asked the same questions of AIM-listed Advanced Oncotherapy (AVO) twice before but there has been nothing forthcoming from Advanced Towers. Here we go again, on the day that marks three weeks from the end of Advanced’s loan from Blackfinch, a loan which is secured on its Harley Street premises and a loan which has not yet been announced to have been paid back. Advanced may be coy about answering, but it seems the market has been voting with its feet.

AVO
AVO

Advanced Oncotherapy – what of that Blackfinch loan (which was due on 24 March)?

It is now a week into April, yet AIM-listed Advanced Oncotherapy (AVO) has not updated on its loan from Blackfinch which was due to be repaid – I thought – at the end of March. In fact, it appears that the loan matured on 24 March. Worse, the loan was secured on Advanced’s Harley Street site and, it seems, the equipment earmarked to be installed there. One wonders what would be left if Advanced lost that. Surely a statement is a fortnight overdue as to what is going on?

Bearcast

Tom Winnifrith Bearcast - Possibly the best podcast ever - Sam Antar is the King

Not this one but one I recorded yesterday with my pal the king fraudster Sam Antar who created the original Panama Pump. Sam was on fine form and I shall unleash that podcast in a couple of weeks time but it was awesome.  I pick up on a few themes from it and discuss Ascent Resources (AST), Advanced Oncotherapy (AVO) - read Nigel's brilliant piece, about a company where I own 1 share so I can attend GMs,  HERE - and Strat Aero (AERO). If you like bearcasts then remember that at UK Investor on April 21 one of many highlights will be a live bearcast with myself and Paul Scott. Make sure you book a free ticket HERE using the promotional code WINNIFRITH.

Listen to the Bearcast:
AVO
AVO

Advanced Oncotherapy – are the wheels coming off the Yantai white knight bailout?

Yesterday AIM-listed Advanced Oncotherapy (AVO) announced that the Long Stop Date for the completion of a Distribution Agreement with Yantai Cipu, already extended to 31 March, had been exceeded but discussions were continuing. This deal also involves the payment of £16.5 million to Advanced and it seems the cash is yet to arrive – indeed I wonder if the £13.5 million subscription cash arrived. That in turn leaves me wondering, yet again, what the cash position at Advanced is – and what about the £5.5 million Blackfinch loan which should have been repaid at the end of March (and is secured)? Are the wheels coming off the white knight rescue? Surely a full statement is needed?

AVO
AVO

Advanced Oncotherapy - saved by oriental white knight, but for how long?

With a litany of Red Flags behind it, you might wonder that AIM-listed Advanced Oncotherapy (AVO) has managed to raise any money at all, but this morning’s news is – it seems – good news. Cash coming in (and large quantities of it) should pay down the payables nicely and give the company some breathing space – although we are told that the cash is still in China awaiting approval to be shipped out by the authorities. Followers of the ShareProphets AIM-China Filthy Forty might consider that as an indication that the completion of the deal is rather open to question.

Bearcast

Tom Winnifrith Bearcast: ADVFN & Online talk 100% crypto-bollocks - does anyone swallow this shite?

Today Joshua and I have coffee with the fit young mums then we are off to go to his first business lunch. I have a work lunch and my boy is coming too. That is the deal for folks wanting to meet up on a Wednesday to Friday. I start today's podcast with ADVFN (AFN) and On-Line (ONL) talking pure 100% unadulterated crypto bollocks. Then it is onto Advanced Oncotherapy (AVO) - good news yes but given its track record of allowing insider dealing, misleading customers and investors and, arguably, wholesale securities fraud I would not buy. I look at The People's Operator (TPOP) and question the wording of today's RNS - the shares are 71% down but this could well be toast by Christmas - look at the wording again! Finally a few words on the latest news from the boiler room and the dog Sabien (SNT) 

Listen to the Bearcast:

Strat Aero placing and open offer - but in best case it is still bust by February!

Cometh the day cometh the broker who will raise cash for any old shite even if it is bust both before and not long after the exercise, as long as it can hand stock at a huge discount to its mates so they can flip and earn lots of lovely jubbly commission as well. Peterhouse Corporate Finance meet Strat Aero (AERO).

Bearcast

Tom Winnifrith Bearcast - Savannah Resources you are so fecking transparent

Some companies are so transparent. I look at the RNS from Savannah Resources (SAV), do the maths and predict a placing within weeks. I then crow about one I called earlier, Applied Graphene Materials (AGM). Then it is onto Interquest (ITQ) which is back on the AIM casino thanks to Nomad Allenby, a firm that I take to task for being morally bankrupt. I look at Johnston  Press (JPR) which is nothing to do with Luke Johnson who is also mentioned. I then look at Advanced Oncotherapy (AVO) and i3 Energy (i3E) as well as the dog Haydale (HAYD) 

Listen to the Bearcast:
Bearcast

Tom Winnifrith Bearcast - the weirdest rumour re Advanced Oncotherapy, Sound hype is exposed by the acid test, now for the fit young mums

I must rush. The fit young mums are waiting. Ahead of that, Advanced Oncotherapy (AVO) really should comment on the weirdest rumour which I relay. Redcentric (RCN) answers one question but many remain. Then Sound Energy (SOU) hype takes the acid test of a trade sale of its Italian assets and the real value is exposed. Sound really is so much hot air. Finally a look at the CVA and rape of shareholders and creditors of Kin Group (KIN)  by broker Peterhouse and the new, crony capitalist, directors.  

Listen to the Bearcast:
AVO
AVO

Advanced Oncotherapy Interims: cash-guzzler extraordinaire but the tank is empty

AIM-listed Advanced Oncotherapy (AVO) has released its interims results on deadline day. The highlights (if that is the right word) come from the cashflow statement, where cashburn appears to be almost £2 million a month. And then there is the company’s statement of working capital which, although technically correct, is a grossly misleading figure.

Bear

COMPETITION - Interim Results deadline tomorrow, how many dismal showings?

We know how much you all like a good competition - especially when there is no prize whatsoever! So with deadline day tomorrow for interims - and a good few still being worked on it seems - how many disappointments will we get by the close of the RNS system tomorrow night?

AVO
AVO

Advanced Oncotherapy – is a family member of boss Dr Mike Sinclair worth £269,265?

Shares in AIM-listed Advanced Oncotherapy (AVO) are still languishing well below the par price of 25p and the company must surely by now be running pretty low on cash. But a look at the FY16 accounts throws up some interesting questions over remuneration.

Bearcast

Tom Winnifrith Bearcast - BNN shareholders take it up the Arsenal

Links with Arsenal, massive cash burn, China, always missing goals (like the Arse) - that was BNN Technology (BNN), shares in which have been suspended today along with its CEO and China boss. I look at BNN in detail plus Telit (TCM), UK Oil & Gas (UKOG) after my weekend pieces HERE and HERE. I cover Blenheim (BNR) after its joke RNS today and also the dog Advanced Oncotherapy (AVO) after its latest spoof. The Mrs says my headline is crude & arguably homophobic, but I know you will love it and it is not if you take it in context.

Listen to the Bearcast:

My top four short-able shorts in London

It is all very well saying that tiddly little companies like Advanced Oncotherapy (AVO) or Eden Research (EDEN) are worthless cash guzzling frauds heading for 0p but they are just very hard to short. That both stocks will hit zero is a given. In the end frauds always run out of other people's money. What you want are stocks you can short which look almost certain to collapse. And right now you need them badly as a hedge. A hedge against what?

AVO
AVO

Advanced Oncotherapy – how’s the cash position? Still a stonking SELL.

After a stack of RNSs earlier this year, it has all gone quiet at AIM-listed Advanced Oncotherapy (AVO) since the announcement of the termination of the Bracknor death-spiral. How’s the cash position?

PCG Entertainment – Lots to like about this funding deal other than…….WHY??

Like Richard Poulden, CEO of PCG Entertainment (PCGE), I have a bit of time for Brian Kinane at Riverfort. As someone who believes in transparency and clear communication, my view is that Brian is trying to bring some of that to the world of small cap funding, particularly where the dreaded phrase “ death spiral” is concerned and there’s a few points here to be applauded. It still doesn’t prevent the obvious question being aimed at Mr Poulden though – WHY RAISE MORE FUNDS NOW?

AVO
AVO

Advanced Oncotherapy – ignore director buying, it’s a spoof

AIM-listed Advanced Oncotherapy has announced a director buy of 100,000 shares (about £17,750 worth). Dr Enrico Vanni, a NED, has gone into the market and hoovered up a few more shares to add to the series of shares acquired earlier this year as the company tried (and failed) to defend the 25p (par) share mark in the face of the Bracknor death spiral sales. Now he’s back.

AVO
AVO

Advanced Oncotherapy - technological milestones, but what about cash?

AIM-listed Advanced Oncotherapy (AVO) has announced that the final Coupled Cavity Linac (CCL) module (part of the LIGHT system) is ready for shipment to the company’s Geneva Testing facility. All very good news, no doubt, but what is the cash position of the company?

AVO
AVO

Advanced Oncotherapy – what is the position re Bracknor? Has it been paid off?

Tom and I covered this the other day, but I wonder whether we’ve missed a trick with regard to AIM-listed Advanced Oncotherapy (AVO) and its dealings with death spiral sharks Bracknor. Immediately prior to last week’s funding news my back-of-an-envelope calculation was that Bracknor still held £1.95 million of loan notes and a further £0.7 million from fees. Given that Bracknor held little (if any) shares, why has it not beaten a hasty track to get the loans converted so that it can sell into the resulting strength?

Bearcast

Tom Winnifrith Bearcast - The PLC Death List Update - 9 new entrants

I started the PLC death list in June 2015 with 21 members. The aim is to pick stocks that will either go bust or get slung off the AIM Casino. Each departure requires a nreplacement. With nine new entrants today 40 names have joined this select group. So far there have been two outright failures on my part, Mariana Resources (MARL) and Jersey Oil & Gas (JOG). There was one volte face but I was ahead at volte face point and it was a great call both short and long - Wandisco (WAND), two near kills, InternetQ (INTQ) and Monitise (MONI) and thirteen slam dunk kills: Cloudtag (CTAG), Worthington (WRN), African Potash (AFPO), Jiasen (JSI), Camkids (CAMK), China Chaintek (CTAK), JQW (JQW), Afren (AFR), Daniel Stewart (DAN), Sefton (SER), Outsourcey (OUT - boy I enjoyed that one - Afriag (AFRI) and Auhua. So 13 out of 31 = 40%+ - not bad eh?  Arguably that is 15 out of 31 - almost 50%! That leaves:

AVO
AVO

Advanced Oncotherapy – Bracknor gone, new loan for £3.9m. Is all suddenly rosy in the garden? Er…

AGM day for AIM-listed Advanced Oncotherapy (AVO) and it has pulled something out of the hat. The shares have shot higher, death spiral outfit Bracknor is history and Advanced doesn’t look like going bust now for at least 4 months. But is the deal as good as believed? Er..no.

AVO
AVO

Advanced Oncotherapy now just 10p to sell. When will Bracknor walk – or has it already?

Cynical Bear wonders whether there might be a read across to AIM-listed Advanced Oncotherapy (AVO) from today’s news from suspended-pending-clarification Kin Group (KIN) in the wake of its announcement that its funding partner had walked because the share price had fallen so far. Certainly, given the cash-back situation for any loan note conversion by Bracknor into Advanced shares there looks to be a point at which the situation breaks down..

AVO
AVO

Advanced Oncotherapy - is that the whiff of panic I smell at death spiral provider Bracknor?

Shares in Advanced Oncotherapy (AVO ) are again tumbling on this fine summer's day. Oh what joy it is to be alive. 350p at peak ramp less than two years ago, they are now just 10.75p to sell. Ouch, I just love the smell of burning share certificates belonging to Bulletin Board Morons in the morning. So what crisis looms? Take your pick.

Sheriff-Of-AIM

Reader poll: Who has been stupid enough to send Tom Winnifrith a lawyer's letter now?

Don't these fools ever learn? For chancers and crooks like Darren Winters, the shysters at Globo, Blinkx, Quindell and Daniel Stewart and for lyin Chris Cleverley and Lord Hain of sleaze and for so many others, sending me a fascist lawyers letter never works out well. That is not for them at least. But it seems there is one born every day. A new letter is in demanding that three years of articles be removed, that damages and costs be paid and that I put my name to a grovelling apology dictated by this poltroon. Who do you think is daft enough to have sent it? Vote now in our latest poll with a deadline of midnight tonight.

AVO
AVO

Advanced Oncotherapy - the ramps become ever more pathetic - today's reeks of desperation

The stench of desperation at AIM POS Advanced Oncotherapy (AVO) is overpowering.It knows that insolvency looms, that the money is running out fast ( within weeks?) and that a blizzard of share sales from death spiral provider Bracknor will obliterate the share price in the last few days. The board know it. The advisers must know it. But they cannot bring themselves to admit it. The pretence goes on for a while yet. And thus today we have an RNS.

Clown

New Bulletin Board Moron of the Week contest - sponsored by Paul "Queenie" McManus PR to London's worst frauds & AIM trash

Queenie smears journalists and spins for all the worst companies on the casino from fraudsters Eden to Advanced Oncotherapy to Norfolk's finest Fusionex. He truly is a posterboy for AIM and thus a fitting sponsor for this week's contest.  The challenge: We're looking for exemplary examples of sheer stupidity from those founts of brilliance; the Bulletin Board Morons who dwell on the cesspits that are LSE.co.uk, III.co.uk and ADVFN.co.uk. The deadline to post your entries in the comments section below is midnight, Sunday 2 July.

AVO
AVO

Advanced Oncotherapy - letter to Financial Reporting Council re uber dodgy accounts

In a sense this is not that relevant as Advanced Oncotherapy (AVO) is within a couple of months of running out of cash and going tits up but on a point of principle I have written to the my very good friends at the Financial Reporting Council as there are aspects of Advanced's 2016 annual report and accounts which stink more than a pile of rotting kippers left out at a sewage farm in the scorching midday heat. The letter follows:

AVO
AVO

Advanced Oncotherapy – Annual Report published: Guess what?????

AIM-listed Advanced Oncotherapy (AVO) has released its full Annual Report. Having looked yesterday at a few things I thought it would be worth a second look – especially in the light of a clean audit report from RPG Crouch Chapman. Mea culpa to myself and Tom who expected something different, but hang on a minute…

AVO
AVO

Advanced Oncotherapy – when the Final Results don’t tell you everything you need to know

AIM-listed Advanced Oncotherapy(AVO)  has released its final results RNS for 2016 with four days to go before deadline day  Bully for Advanced. But there are no notes to the accounts and why is there no no auditor’s statement – the very things that we were looking for. What is the company hiding? We are told that the report WILL be made availlable on the website but hang on...this is crucial!

AVO
AVO

Reader Poll Advanced Oncotherapy share price by close of play Friday?

Advanced Oncotherapy (AVO) shares have fallen from a ramptastic peak of 350p to just 13.5p to sell as at last Friday. But sell you should as I explained again today HERE. The question is what will the shares be trading at ( mid) as at next Friday which is a critical deadline. What do you think? Let's gloat on the professional graves of scumbag crony capitalist Dr Michael Sinclair, arch share ramper Alan Green and PR low life Paul "Queenie" McManus. With a deadline of 7 AM Monday 26th vote now in the poll below.

AVO
AVO

Tom Winnifrith: I lied to you - I have a 19th share, I'm 99.75% down in four months and over the moon

Yesterday I revealed to you the 18 shares I own and thanks for all the comments. For the avoidance of doubt that portfolio started at zero four and a bit years ago and we have more than trebled our money to date. It happens. But I lied to you, the portfolio is incomplete. I own two other shares. 

AVO
AVO

Advanced Oncotherapy – another death spiral conversion as the company admits it is looking for alternatives

AIM-listed Advanced Oncotherapy (AVO) has announced the latest death spiral on steroids conversion by Bracknor: £400,000 into 1.6 million shares. But with the shares sitting a country mile below the 25p nominal price they have to pay £190,000 back. That works out as 11.875p per share and thus means that Bracknor gets its new confetti at just (effectively) 13.125p. Not bad, bearing in mind that the lowest daily VWAP came in at 15.79p.

MSG
MSG

Milestone - another bailout placing ahoy from the AIM Rule Breakers

The underlying problem with Milestone Group (MSG) is that it is a crap business that never generates any cash. Thus in order to keep CEO Deborah White in the lifestyle to which she has become accustomed and to keep paying crony capitalist advisers such as shamed PR firm Walbrook (Eden, Fusionex, Advanced Oncotherapy etc) it relies on bailout placing after bailout placing with shareholders seeing value destroyed every time.

FXI
FXI

Fusionex - votes to delist: shares now 33p to sell - worthless:: CEO Teh talks horseshit, has Nomad quit?

Surprise surprise shareholders in Fusionex (FXI) voted to delist the shares from AIM. Management and stooges had the vote sown up anyway so won 85% to 15%. The shares will cease trading on 26 June. CEO Ivan Teh must have really pissed off the owners of 5.4 million shares who voted against.

AVO
AVO

Advanced Oncotherapy - new loan, now desperately borrowing against VAT receivable, 0p within weeks

I have never seen a loan like this. It is sheer desperation from a company that faces imminent insolvency. Make no mistake, Advanced Oncotherapy (AVO) is on the way out and corporate death will occur very soon indeed.

AVO
AVO

Advanced Oncotherapy – the stench of desperation as the shares crash

Shares in doomed Advanced Oncotherapy (AVO) are now 15.25p to sell, compared to a 25p nominal price. That means that as death spiral provider Bracknor desperately tried to convert c£3 million on loan notes into shares to flog to eliminate its exposure under the spoof arrangement with Advanced it will demand fees of 40p for every £1 of loan note converted. As it scrambles to convert notes and flog shares before the fat lady waddles onto stage from the wings (where she is already warming up), the share price will continue to tank making things even worse. So what to do?

AVO
AVO

Advanced Oncotherapy: Bracknor Death Spiral news - this is a sham & 0p beckons fast

With its hand forced by my article HERE, Advanced Oncotherapy (AVO) has clarified, i.e. changed, the terms of its death spiral deal with loan sharks Bracknor. It states "This reaffirms Bracknor's prior and on-going support for the Company and its shareholders." Dr Michael Sinclair you are talking bollocks. It has changed a death spiral to a death spiral on steroids. 

AVO
AVO

Advanced Oncotherapy- where's the statement you goddamn shysters?

Wakey wakey Michael Sinclair and the other tossers who run Advanced Oncotherapy (AVO). Time to get out of the luxury gym ( membership fees paid by grateful shareholders) - you need to be issuing a statement don't you? Bracknor? 10 days? Capital Reorganisation? Ring any bells? Come on, call your useless PR man Paul Queenie McManus and tell him to stop promoting the Eden fraud and get a release ready for you.

AVO
AVO

Advanced Oncotherapy – EGM clock ticking again as shares resume slide

I can’t help but notice that in the wake of a couple of Bracknor death-spiral loan note conversions, shares in AIM-listed Advanced Oncotherapy have rather slipped again. Indeed, having scraped onto the 27.5p watermark on Monday last week (and thus avoided an EGM to drop the nominal price of the shares) as the result of spoof boardroom buying, it has been one-way traffic ever since, down to 22.75p last seen.

AVO
AVO

Advanced Oncotherapy – another Bracknor Conversion, but look at the terms: how’s the Going Concern statement coming along?

Well, well. How do you issue shares at a discount to par? Simple: pay a whopping fee to the subscriber. AIM-listed Advanced Oncotherapy (AVO) has announced another loan note conversion under its death-spiral funding package with Bracknor and a new fee seems to have appeared which might just derail discussions between the company and its auditor as they work on the going concern statement for the forthcoming FY16 results due out by the end of next month. Oh dear, oh dear.

AVO
AVO

Advanced Oncotherapy – yet another director ponies up, EGM seemingly avoided and Bracknor converts. Most bizarre

Well this is most bizarre! Lobster-potted Bracknor has converted another lump of its death-spiral loan notes. That, of course, is not a great surprise until you study the detail of yesterday morning’s announcement from AIM-listed Advanced Oncotherapy (AVO), where we discover that the conversion shares have been issued not at the lowest daily volume-weighted average price of the past 15 days (21.35p) as per previously announced conversion terms, but at 25p (par price of the shares). Why has Bracknor elected to pay a 17% premium?

AVO
AVO

Advanced Oncotherapy – a last-ditch effort to avoid an EGM?

Well it looks as though D-day is today after all for the triggering of an EGM to drop the nominal (par) price of AIM-listed Advanced Oncotherapy (AVO) stock so as to allow Bracknor to resume its convert-and-dump operations. With the shares edging a little higher this morning, one is tempted to wonder whether some heavy boardroom buying might be enough to lift the shares back over the 27.5p mark just in the nick of time. But there is a fair way to go, with the stock still 2.25p short of salvation. 

AVO
AVO

Advanced Oncotherapy – is it D-Day today, or Monday?

Under its Bracknor death-spiral funding package, AIM-listed Advanced Oncotherapy (AVO) has to call an EGM proposing resolutions to drop the current nominal, or “par”, 25p price of its shares by at least half in the event of 10 consecutive closes below 110% of nominal (ie below 27.5p). But the company has never defined the closing price used: is it mid-price, bid-price, offer-price at close, or perhaps some more convoluted closing daily VWAP (volume weighted average price) calculation? But one thing is for sure, the match is right next to the blue touch-paper. Is it today or Monday, fellas?

AVO
AVO

Advanced Oncotherapy – another day, another spoof? Spot the missing statement....

Advanced Oncotherapy (AVO) has announced that NED and highly respected senior clinical oncologist at Great Ormond St and Barts Dr Nick Plowman “will” invest £250,000 in the company – at 30p a share, a 36% premium to last week’s close. Why am I not convinced that this morning’s announcement is anything other than the most desperate of spoofs in a long line of spoofs here?

AVO
AVO

Reader Poll results: Advanced Oncotherapy share plunge - when will it hit 0p?

ShareProphets readers don't expect an immediate implosion on Advanced Oncotherapy (AVO). They're leaving it to Father Christmas to do the job. We asked you when the shares would hit 0p - you said!

AVO
AVO

Advanced Oncotherapy share plunge - when will it hit 0p? Reader Poll

Shares in AIM dog Advanced Oncotherapy (AVO) closed Friday at just 21p. That is below the 25p nominal meaning that death spiral provider Bracknor cannot convert any more loan notes without taking a huge loss and, if that continues, it means the company will go tits up in the summer. Or the former Malcolm Stacey darling will need to approve a capital reconstruction to set a new nominal (2.5p?) which will see the shares plunge, so meaning Bracknor physically can't convert loan notes so Advanced will go tits up this summer. So when will its shares hit 0p or be suspended from AIM? Vote now in our reader poll - deadline midnight tonight.

AVO
AVO

Advanced Oncotherapy – the 25p dam bursts. What now for Bracknor as shares resume slide towards the abyss

You can’t say you have not been warned. This morning shares in AIM-listed Advanced Oncotherapy (AVO) have fallen firmly below the nominal 25p price of the confetti. Companies are not allowed to issue shares below their nominal price and that, in turn, means that for the time being Bracknor is lobster-potted with something like £2.5 million of convertible (death-spiral) loans which it cannot convert. My heart bleeds….

AVO
AVO

Advanced Oncotherapy – Uh-oh: Aviva bailing as 25p nominal dam buckles under the strain

Oh dear. Oh dearie me. AIM-listed Advanced Oncotherapy (AVO) has released a TR-1 from institutional investor Aviva showing that it has been dumping shares and went below the disclosable threshold to 2.44% last Friday in terms of its directly held interests. It had a further 0.66% interest via loaned out shares. Meanwhile Advanced Onco shares today fell below the 25p nominal price of its confetti, leaving death-spiral funder Bracknor in a bit of a pickle just five days after ponying up tranche 2 of convertible loans which it can’t convert for less than 25p. Ouch.

AVO
AVO

Advanced Oncotherapy – looking at the record of the Exec Chairman, Part 5 (final chapter)

The final two pages of listings of AIM-listed Advanced Oncotherapy (AVO) Exec Chairman, Michael Jeffrey Sinclair’s company officer posts on the OpenCorporates.com website add another 27 entities to our previous tally (after ignoring a further 6 double entries) of 113 appointments to bring the total up to 140 jobs in an illustrious career. And so we have the final scores-on-the-doors – as well as an interesting observation.

Newsboy

Notes from Underground: All creature great and small, Tom poisons the lot

In the past seven days, 43,154 unique readers read 70,771 pages on ShareProphets. The circulation of the Investors Chronicle is c30,000. Shares is less than half of that. To our critics who think we do not count, we say think again.

AVO
AVO

Advanced Oncotherapy draws second tranche of Bracknor funds but who is paying for what at Harley Street?

AIM-listed Advanced Oncotherapy (AVO) has announced this morning the drawdown of the second tranche of £1.3 million (nominal - £1.235 million after the 5% discount) on its convertible loan note (aka death spiral) package with Bracknor. Good news – the lights will stay on for a few weeks extra. But the second half of the statement is a bit of a puzzle, raising more questions than it seemingly tries to answer.

AVO
AVO

Advanced Oncotherapy – another spoof from the kings of spoofery as this time Exec Chairman buys

Well that explains it then! Yesterday I noted my amazement that AIM-listed Advanced Oncotherapy (AVO) had issued yet another ramparoonie director share purchase RNS on Tuesday and that the shares had raced back above not only the all-important 27.5p mark, but above 30p. Now we know why: Executive Chairman Dr Michael Sinclair was in the market filling his boots with 200,000 shares  at an average price of 30.44p. Shame he didn’t pile in when the shares were hovering around the 26p mark so as to save himself a few quid.

AVO
AVO

Advanced Oncotherapy: looking at the Exec Chairman’s Record – part 4

We are nearly there. Hurrah! The OpenCorporates.com website lists 153 company appointments for a Michael Jeffrey Sinclair spanning some six pages. Today we move into page four to see how the rate of dissolutions looks.

AVO
AVO

Advanced Oncotherapy draws £2m second tranche from Blackfinch, Bracknor converts another £200k

At no-one-is-watching o’clock last night (5.48 pm) AIM-listed Advanced Oncotherapy (AVO) slipped out an announcement that it had drawn the £2m second tranche of cash available under its one-year loan deal with Blackfinch. With my maths suggesting that the company was close to running on fumes that extra £2m to keep the show on the road pro tem will come in handy.

AVO
AVO

Advanced Oncotherapy – looking at the Exec Chairman’s record, Part 3

Phew! 153 company directorships to plough through from the career of AIM-listed Advanced Oncotherapy’s Executive Chairman. He sure has been a busy chap. Actually the number is dropping slightly as a few more double entries come up on the OpenCorporates.com website – just as well. Having looked through the first 30 entries on Sunday (29 after sifting out double entries) and the same again yesterday, we come to the next 30 from our search of the career of Dr Michael Jeffrey Sinclair.

AVO
AVO

Advanced Oncotherapy – more spoofery as NED buys yet more shares

AIM-listed Advanced Oncotherapy (AVO) – teetering on the brink of having to call an EGM to reduce its nominal share capital under the terms of its death-spiral funding package with Bracknor – has announced yet another director share purchase, the fourth just this month (if we ignore the botched 7am RNS of 4 April). As ever, this is just a spoof in order to encourage more buying in the market so as to allow Bracknor to offload more of its death-spiral conversion shares as Advanced hopes and prays for the next £1.235 million tranche of funding before the coffers run dry.

AVO
AVO

A look at the record of Advanced Oncotherapy's Exec Chairman

AIM-listed Advanced Oncotherapy (AVO) Exec Chairman Dr Michael Jeffrey Sinclair has, according to the OpenCorporates.com website, served as an officer of 155 companies over his illustrious career. With Advanced Onco facing a few issues of cash as it tries to get its Harley Street facility installed and running, it is perhaps worth a gander through this record. Here are the first 29 listed on the OpenCorporates.com website (actually it is 30, but one appears to be a double entry so has been removed).

AVO
AVO

Advanced Oncotherapy – more on that Blackfinch secured loan: is it pre-pack ahoy?

As shares in AIM-listed Advanced Oncotherapy (AVO) again sit below that all-important 27.5p mark which, if continued for 10 trading days, will trigger a EGM to reduce the nominal value of the company’s shares, a quick trip to the Companies House website reveals the debenture paperwork (HERE) related to the company’s recently announced loan deal (with spoof 100p conversion terms) with Blackfinch as announced on 27 March (HERE). Most of it is legalese, but on page 36 we get some cracking tit-bits. Such as the planned expenditure on the Harley Street premises (some £19.14 million) as against potential resale values of between £9.44 million and £10.71 million – and that is just for the kit and fitting, not for the value of the property itself. As security (including the property) for a £3 million loan (with an option for a further £2 million) it is quite something!

AVO
AVO

Advanced Oncotherapy – Bracknor ups the ante, converts £200,000, tick tock to EGM o'clock

This morning AIM-listed Advanced Oncotherapy (AVO) announced another conversion by Bracknor. Having previously converted three lumps of £100,000 of death spiral loans, Bracknor has gone for £200,000 worth this time – but at the lowest price yet, just 26.74p. That leaves things looking decidedly sticky for the company, which got authority to issue Bracknor with enough loan conversion shares based on the assumption of an average loan conversion price of 44p and the associated warrants at 57p.

AVO
AVO

Advanced Oncotherapy – SPOOF, SPOOF AND SPOOF some more

Under its death spiral funding package with Bracknor, AIM-listed Advanced Oncotherapy (AVO) has to call an EGM to seek shareholder approval to reduce the nominal price of its shares (currently 25p) by at least half if the closing share price is below 110% of nominal (ie 27.5p) for ten consecutive trading days. And that brings us to the latest spoof director share purchase announced this morning (which hasn’t worked: the shares are down 4% last seen this morning).

AVO
AVO

Advanced Oncotherapy – Bracknor converts again, shares crumbling: when will the EGM be forced? SELL!!!!

AIM-listed Advanced Oncotherapy (AVO) has this morning announced another loan conversion by its white knight death spiral funding provider Bracknor. The lack of liquidity of late makes it hard to imagine that Bracknor is having an easy time offloading. Meanwhile the shares have again slipped and now sit below the threshold at which an EGM to reduce the nominal price of the shares is triggered. Oh dear….

AVO
AVO

Advanced Oncotherapy – Bracknor converts again but is it selling?, can it sell?

AIM-listed Advanced Oncotherapy (AVO) has announced a second conversion of death-spiral loan by Bracknor. As per the first conversion, it is £100,000 (nominal) but this time the conversion price was just 27.89p. Given that the recent EGM gave approval for the company to convert the full package at an average 44p per share that might mean a bit of a headache.

AVO
AVO

Advanced Oncotherapy – ANOTHER RNS mess-up!

Following the botched Director Dealings RNS of Tuesday, this afternoon AIM-listed Advanced Oncotherapy has ‘fessed up to another foul-up. This time it refers to an RNS released way back on November 7th last year when the company announced that it had issued 266,668 new shares from the exercise of options at 87.5p per share. Except that it hadn’t.

AVO
AVO

Advanced Oncotherapy – another SPOOOOOOOOOF and a screwed up RNS: KEEP SELLING

It seems that AIM-listed Advanced Oncotherapy (AVO) is so desperate to get out any good news it can that it rushed out an RNS yesterday morning to notify the market of director buying and got the numbers wrong. Oops. Great work in checking and verifying there by Nomad Stockdale Securities.

Bearcast

Tom Winnifrith Bearcast on Brexit day - can you guess how this starts?

Heck my family has been waiting 40 years for this day as I explain HERE you must allow me to have some fun! To the markets and I have a detailed look at Sabien Technology (SNT) which is talking absolute bollocks today, at Johnston Press (JPR) and then at China New Energy (CNEL), today's ramp of choice but which stinks to high heaven. Then I discuss whether I have been too harsh on Advanced Oncotherapy (AVO). The answer is that I have not been hard enough. Ahead of a GM on Friday which I am attending the stance remains sell with a target of 0p.

Bearcast

Tom Winnifrith Bearcast - How the Shipmans are buttering up my Dad plus punishing the wrong folks at Tesco

My father is being charmed and buttered up by the quacks at Warwick Hospital and I am off there shortly for a pre operation chat. Ahead of that I look at Tesco (TSCO) and its fines today - we really have got white collar crime all wrong in this country. Then I look at Genel (GENL), Tasty (TAST) which is really not very tasty at all, Advanced Oncotherapy (AVO) which is is utterly inedible and Sound Energy (SOU) where the issue is valuation. Surely the good news is in the price already? 

AVO
AVO

More Bad News for Advanced Oncotherapy

It has arrived! My £52 costs and 32p investment in one share in AIM dog Advanced Oncotherapy (AVO) is not money wasted.

Bearcast

Tom Winnifrith Bearcast - sitting in Shipston it is Cloudtag day! Where is the ouzo Dad?

It seems as if  my father has drunk all the ouzo. Who can blame him? But how will I celebrate if the fraud Cloudtag (CTAG) is booted off AIM today? Join in the fun with our Cloudtag termination clock HERE. Elsewhere I look at Bowleven (BLVN), gosh I loathe its management team, Advanced Oncotherapy (AVO), also run by tossers, and Strategic Equity Capital (SEC).

AVO
AVO

Advanced Oncotherapy - Spooooooooooooooooooooooooooooooooooooof

Ho ho ho. Even as it faces insolvency those wags at Advanced Oncotherapy (AVO) do so with a sense of humour as they try to spoof us all with news of an even more desperate financing which will keep the lights on until late June. Dr Michael Sinclair you should go on the stage. You really are a hoot.

Bearcast

Tom Winnifrith Bearcast: Paternoster Resources why cheap could be incredibly expensive

I comment on the hopeless response of smug MPs and the established media to yesterday's terror attack on my own website in a podcast HERE. On the markets I look at expectations management at Next (NXT), at how we know or knew about the balance sheet at Toople (TOOP) covered HERE by Cynical Bear or Advanced Oncotherapy (AVO) heading for 0p and covered in detail by me earlier HERE. I look at Public Services Properties (PSPI ) and what its AIM casino departure says about RTOs and contingent liabilities - which reminds me again of New World Oil & Gas (NEW). Finally I have a detailed look at the strange world of Paternoster Resources (PRS), not a stock you have to own in any way. PS Cynical Bear is not me. Can you see any typos in his articles?

AVO
AVO

Advanced Oncotherapy - back at 31.5p - is Bracknor dumping or spoofing today? Timber!!!

It is just eight days to the GM of Advanced Oncotherapy (AVO) where shareholders are being asked to approve the issue of gazillions of new shares for the Bracknor death spiral. Since the alternative is going bust within weeks if not days then the result is a gimme although I intend attending - as the owner of 1 share - to ask some searching questions. But the collapse in the share price - the stock is now 31.5p mid, 30p bid tells you there are even bigger issues and that Advanced is, quite possibly toast whatever.

Bearcast

Tom Winnifrith Bearcast - Terror attack on London Edition

Clearly this is the story of the day. I reflect on this from various angles. I then move onto Franchise Brands (FRAN) shares in which surged 16% forcing a suspension. No insider dealing here guv, walk on, walk on. Then it is onto Bowleven (BLVN),  Yolo (YOLO), Starcom (STAR) which I may have called Starvest but I meant Starcom, Van Elle (VANL), Nyota (NYO) and finally the uber dog Advanced Oncotherapy (AVO) which is in freefall. Hah! Death spiral shylocks Bracknor your spoof is not working is it! On the subject of terror I mention that evil bastard Martin McGuinness.You should not speak ill of the dead but for this unapologetic murderer  and for those in the media who praise him as a good man I make an exception HERE.  Mr McGuinness was a wicked man who sought no salvation in apology and repentance and, if there is a hell, his soul is right now burning at the heart of it. 

Bearcast

Tom Winnifrith Bearcast: Wringing the Vicar's Neck, he is a mad Guardian reader

Dad and I got back from the hospital and were sitting down to lunch. water for me, wine for him. After a morning with a range of Shipmans he deserved it. Who should bound in but the vicar from our old village of Byfield. I told him that I had recently written an article about wringing his neck HERE. He then gushed out a stream of left wing views on Trump, Brexit and other matters that were so barking mad that even my Guardian reading father was a bit taken aback. A bitter attack on Uncle Chris Booker was the final straw. No wonder the CofE is going to the dogs.  On the podcast that followed I cover Orogen (ORE) where we are in and backing Adam Reynolds again, Nyota (NYO), Audioboom (BOOM), Andalas Energy (ADL) and Advanced Oncotherapy (AVO).

AVO
AVO

Is Bracknor spoofing investors to postpone the collapse of the Advanced Oncotherapy death spiral?

Death spiral provider Bracknor does not buy shares in companies. It loans the desperate, cash at pound of flesh rates which it then converts into shares at discounted rates and flogs to mug punters. That is the classic death spiral model. But to get such a death spiral away it needs a perception of market liquidity and also to avoid a complete short term collapse of the share price. And that brings us to Advanced Oncotherapy (AVO).

Bearcast

Tom Winnifrith Bearcast: Bob Diamond Panmure Gordon & a crap industry

I have been greatly distracted not least dealing with this utterly brain dead and vile Cloudtag (CTAG) shareholder who has been spamming me with the most ghastly abuse all day. I look at the Bob Diamond bid for Panmure Gordon (PMR) and what it means for the wider broking/corporate advisory sector. I then turn to Premaitha (NIPT) and the wider issue of the pointlessness of commissioned research. I touch on Management Resource Solutions (MRS) in light of the news earlier HERE but now the way it is really trying to screw shareholders with a 5p placing. There is comment on Jubilee Platinum (JLP). Then it is back to two old favourites: Advanced Oncotherapy (AVO) and Milestone (MSG). Woof Woof.

AVO
AVO

Is Hardman Research hiring LSE BB Morons to pen its worthless reports - ref the dog Advanced Oncotherapy

Advanced Oncotherapy (AVO) is, as you know, utterly desperate to create buying interest in its shares so that death spiral shysters Bracknor can dump £13.7 million of equity onto the market over the next year. That is not going well and so Advanced today boasts that it has paid investment analyst prostitutes for hire, Hardman, to publish a glossy note. This report is so unbelievably unbalanced that I can only assume that Hardman outsourced the work to the Bulletin Board Morons on the LSE Asylum. Folks can see through this shite and the shares are down by a penny at just 40p bid which is very bad news for Advanced as explained HERE.

Newsboy

Notes from Underground: Show of Shows

It's with a sharp sense of horror that I realise that it's only three weeks until the the UK's most interesting investing event, the UK Investor Show. Not that the show will be a horror - it'll be terrific - but I'm suddenly jolted into all the last minute things that need to be done on my part and, well, general horror.

AVO
AVO

Advanced Oncotherapy - Get Beer & Popcorn ready for March 31 GM Called - I shall be there!

I have already covered the admissions (HERE) and lies (HERE) flagged up in today's notice of a GM published by Advanced Oncotherapy (AVO). The great news is that the GM is on March 31 in London, a day when I shall be in the Capital. As the proud owner of 1 share bought earlier this week I shall be there for a bunfight. Just 32p for so much fun - bargain! Get your beer & popcorn ready. Why not come along to join me in giving the board hell over all the lies and other matters? There is free beer on me at Wedge Issue afterwards. But there is a far more serious problem for the shysters.

Bearcast

Tom Winnifrith Bearcast: Highlands Natural - Renegade, Rum & Coke

In today's bearcast I look in detail at Highlands Natural Resources (HNR) a true POS. I cover Angus Energy (ANGS), Saffron Energy (SRON) and Advanced Oncotherapy (AVO). 

AVO
AVO

Advanced Oncotherapy forced to fess up on Death Spiral Provider Bracknor & Short selling

Heading to zero, serial liar Advanced Oncotherapy (AVO) has today called a GM to approve the issue of a blizzard of shares to obliterate its share price via death spiral. More on that later but the documentation throws up another issue other than the lies refered to earlier HERE, why will Advanced NOT come clean on short selling by death spiral provider Bracknor.

AVO
AVO

Advanced Oncotherapy - here is a lie it published ahead of that last placing, and another on placing day

Advanced Oncotherapy (AVO) has today called its GM to approve the issuance of more shares to feed the Bracknor Death Spiral - more on that later for the document is, like the company, a joke. But first lets go to a big fat monstrous lie it told last year to help get that bailout placing away in September.

Bearcast

Tom Winnifrith Bearcast: An ethical fight as I Prepare for a day of nappy changing

On the agenda today, I start with a twitter spat with Hugo Rifkind a man who is where he is today thanks to who is Daddy is not his innate lack of talent and who is tweeting nonsense about a matter he has no experience of. After that thrill there is news on UK Investor Show, nappy changing, the ethical dimension in investing in pharma companies, Advanced Oncotherapy (AVO), W Resources (WRES),Domino's Pizza (DOM) and a discussion about residential property and non resident speculators.

AVO
AVO

Has Advanced Oncotherapy broken covenants on Metric loan already - will it be insolvent on March 31 or is it there already?

I am beginning to think that the 32p I invested in buying one share in Advanced Oncotherapy (AVO) may be dead money sooner than I think. The silence on certain matters relating to the £11 million it owes Metric is deafening and leads me to believe that on March 31 this company could be insolvent. Or is it already insolvent?  The first question is whether Advanced has breached covenants on the loan already and so is in technical default, i.e. insolvent. If that is the case investors should be told at once should they not. Perhaps hapless Nomad Stockdale might force a clarification of this matter?

Bearcast

Tom Winnifrith Bearcast: I am now officially at war with Advanced Oncotherapy and have bought 1 share in the POS

Yesterday I asked Advanced Oncotherapy (AVO) to answer 16 questions. I regret to say that as at 12 noon today now undertaking had been given to answer the questions and that therefore I am now at war. As such as I celebrated International Women's day by having a good looking 28 year old blonde run her fingers through my hair I decided to buy one share in this POS company. Bring on the EGM and AGM says The Sheriff of AIM and I hope that other folks out there will also buy one share so that we can get the mothers on this board to answer some very valid questions. In this podcast i also look at how if I was running the fraud at Eden (EDEN) I would buy some time before all is revealed. I also comment on Solo Oil (SOLO) and on the budget and our irresponsible chancellor Hammond who is the real villain of sterling weakness, not Brexit.    

AVO
AVO

When you know a company is finished - sentiment on a Bulletin Board: ref Advanced Oncotherapy

Shares in Advanced Oncotherapy (AVO) are sliding again today. Last time I looked they were 32p bid and they are heading rapidly towards the 25p mark at which point Bracknor will not be able to forward sell/convert loan notes as explained HERE without GM sanction. Thus the loan shark death spiral provider - which is pro tem exposed to the tune of well over £1 million will be flogging shares as fast as it can. Meanwhile Advanced just won't answer my 16 questions HERE. But there is something else going on which you can see if you check out the Bulletin Boards and it is quite remarkable and shows this company is toast.

Bearcast

Tom Winnifrith Bearcast - Extreme Bad Language Special because AIM is an ffing joke

If you object to bad language do not listen. The madness and corruption of AIM, the willingness of the crony capitalists to deceive investors to get away another placing just got to me. In today's podcast I cover Blur (BLUR) - but would commend young Steve's coverage which is superb HERE, FastForward (FFWD) - the Jim Mellon spoof - Advanced Oncotherapy (DOG), Independent Resources (IRG), Amur Minerals (AMC), Sunrise Resources (SRES) and Zenith Energy (ZEN). 

AVO
AVO

Advanced Oncotherapy - Question 16: were you lying on November 24?

Cynical Bear says that I am just being far too kind to Advanced Oncotherapy (AVO) with my 15 questions earlier today. Oddly I have yet to get an answer and nor will I as the company contemplates insolvency and other matters. But back to Mr Bear who says I should have asked a 16th question concerning another possible case of lying.

AVO
AVO

15 Questions for Advanced Oncotherapy: shares crash as Investor Presentation bombs

For years Advanced Oncotherapy (AVO) has ramped its shares to get away placing after placing with ramptastic investor presentations. But that was before I started asking all those horrible questions for which there was no answer. and Winnileaks started obtaining toxic leaked emails.  Last night the company had a presentation in London. It has another in Zurich this morning. Warning Swiss folk and tax dodgers quotes about the London chinwag include "everyone left unhappy" and from a long term bull "I am just throwing in the towel." The shares have crashed by 23% to 36p bid so far today. The target for me remains 0p. But for those folks going to the Zurich meeting here here are 15 questions Advanced can't or won't answer:

AVO
AVO

Advanced Oncotherapy - Death Spiral accelerating, what about the 25p hurdle?

When AIM uber dog Advanced Oncotherapy (AVO) announced that instead of going for non dilutive funding ( as no-one would provide it) it was being forced to resort to a dreadful £13 million death spiral from loan sharks Bracknor, its shares were 65p. When the death spiral started the shares were 58p. Now it just £100,000 of the death spiral loan notes on the first £1.3 million tranche converted, the shares are just 43p to sell. Bracknor now has three reasons to panic.

XTR
XTR

Xtract Resources – Guess it must stand for Damp F***ing Squib

Hallelujah! Xtract Resources (XTR) finally managed to issue the long-awaited DFS at 4.23pm on 28 February. It’s taken me a bit of time to comment on it as I’ve been scratching my head thinking to myself: “Is that it? Is there a page missing? What now?”

Bearcast

Tom Winnifrith Bearcast: For whom the (front door) bell tolls

The bell in this podcast is not Aidan Earley's libel suit arriving but the workmen returning after lunch. I explain why they are here - blame the Mrs. In terms of stocks I cover Prairie Minerals (PDZ), IGAS (IGAS), Milestone (MSG), Xtract Resources (XTR), Amur (AMC), Advanced Oncotherapy (AVO), NCC Group (NCC), Northern Petroleum (NOP) and Saffron Energy (SRON), Redcentric (RCN), MXC Capital (MXCP) and a few other matters. Smiley face.

AVO
AVO

Advanced Oncotherapy share slide accelerates as the death spiral dance moves up a gear

Advanced Oncotherapy (AVO) the company with sod all cash, that is a cash guzzler, with no sales and which has persistently misled both investors and customers has moved up a gear with its death spiral funding and the shares have fallen again to just 49p to sell. Boy how sleazey former director, the Blair crony, Lord Evans of Watford must be glad that he dumped all his shares at 120p just ahead of the last big placing and during a closed period. And there has been no sanction at all. Bully for him. Now back to the death spiral.

Tom

Tom Winnifrith: a fitting epitaph for my gravestone

Actually I am not sure I am going to have a gravestone. I have not amended my will for a while but last time I looked I was heading for a cremation with the ashes scattered in two places. But I am thinking a bit more about a burial these days, perhaps one of those natural ones in a coffin that helps the worms gain easy access and turn you into food for the trees above. So if I do have a stone what shall be on it? I think I have decided

AVO
AVO

The broker that raised £10m for Advanced Oncotherapy downgrades its stance on the dog to hold - damning note

If you had raised £10 million for the AIM dog Advanced Oncotherapy (AVO) less than 5 months ago at 100p then your stance on the stock - at 54p-58p- would be some sort of buy. Oh no. broker Beaufort who did indeed raise that cash has today downgraded its stance to, what may be termed a corporate "hold" (i.e. sell) and makes it clear that the shares will fall allowing lower entry points. I should cocoa. Beaufort today opines after the Bracknor death spiral announcement of Friday - the underlines are mine:

AVO
AVO

Advanced Oncotherapy - The Death Spiral dance begins....timber!

Having promised "non dilutive funding" ad nauseam, on Wednesday AIM listed POS Advanced Oncotherapy (AVO) announced a £13 million death spiral funding with are shylocks Bracknor. On Friday it drew down tranche one and promptly served up another dose of smoke and mirrors for punters. The death spiral dance is now underway. Advanced announced that:

Malcolm-Sax-Machine

Buy, Sell or Hold? Here's How to Make Those Awful Decisions.

Hello Share Swingers. The most arduous element of share-shifting is having to make big decisions, knowing that the wrong choice can cost you thousands of pounds. But which is the correct way to make a choice? As the markets are not open at the weekend, this is a good time to examine the ensible way to make a your decisions in future.

Bearcast

Tom Winnifrith Bearcast: Gosh some Amur shareholders really are as thick as pigshit & don't y'all love our new Cloudtag countdown clock

Don't you just love our new Cloudtag (CTAG) countdown clock on the right hand side of this page? I am already assembling material old and new for this presentation at UK Investor but the clock is a jolly jape is it not? Elsewhere I never cease to wonder at the stupidity of some investors. I look at Amur (AMC) in this respect. I then look at Weatherly (WTI) which is telling you, plain as day, that its shares are worthless. I explain a few hard facts and ask new questions about Advanced Oncotherapy (AVO) and then have a butchers at Rosslyn Data (RDT) shares in which have just hit a new all time low. I wonder why? Smiley face, smiley face.

AVO
AVO

Advanced Oncotherapy: Metric the £11 million black hole and insolvency by March 31?

Yesterday I pointed out how the £13 million death spiral Advanced Oncotherapy (AVO) had signed with loan sharks Bracknor would see its share price collapse. It should but there is worse news in store - that of insolvency looming in just five weeks time. Insolvency you say? What are you talking about? Let me explain.

AVO
AVO

Advanced Oncotherapy - the Bracknor Death Spiral explained Part 2 - this is just so bad, it is awful.

I have noted before that some death spirals are in fact a decent way for companies to raise cash, cheaper and less share price destructive than a bucket shop placing. But the Bracknor deal announced today by Advanced Oncotherapy (AVO), which had promised non dilutive funding but clearly does not mean a word it says, as I explained here earlier, is a total rotter. It will crater the share price as Bracknor makes a killing. Let me explain why.

Bearcast

Tom Winnifrith Bearcast: When are the placings at dog Corero and uber-ramp Amur?

When it looks like placing ahoy, sounds like placing ahoy and smells like it is placing ahoy it usually is placing ahoy. I look at the numbers for Corero (CNS) and Amur Minerals (AMC). In this podcast threatened by the greed of morbidly obese three legged cat Oakley, I also cover NCC Group (NCC) following up from yesterday's late in the day article, Advanced Oncotherapy (AVO) Beowiulf (BEM) and TrakM8 (TRAK).  I also look at the laughable PR of worthless crap company Fitbug (FITB). There is a stand alone bearcast on the joke news from Servision (SEV) HERE

AVO
AVO

Advanced Oncotherapy announces death spiral Part 1: Will it apologise for misleading investors on that one? And is Metric loan now off?

Serial misleader and worthless bag of AIM listed shite Advanced Oncotherapy (AVO) today announced that it has secured death spiral financing for £13-26 million from the lowest of the low DS funders, Bracknor. That is bad enough and will see the shares forward sold to buggery, as I will outline in a separate piece. What is worse is that it exposes Advanced for again misleading investors.

AVO
AVO

The Coca Cola Penis Bulletin Board Moron of the week winner is...

Last week's Bulletin Board Moron contest produced a number of splendid entries demonstrating that the "World's Most Successful Growth Market" attracts "the World's stupidest investors". You can see the full range here but the winner is an Advanced Oncotherapy (AVO) owning moron.

AVO
AVO

Advanced Oncotherapy - the truth finally dragged out of the shysters

Advanced Oncotherapy (AVO) has finally fessed up to the truth of its bust up with Sinophi and is paying the Chinese $250,000 to settle - even last week house broker Beaufort was, with an Advanced steer, suggesting the Chinese would be paying Oncotherapy several million quid. Lets remind ourselves of a timetable of lies, deception and non disclosure.

AVO
AVO

EXCLUSIVE: Sinophi accuses near insolvent AIM dog Advanced Oncotherapy of lying AGAIN

This is becoming something of a ritual. Advanced Oncotherapy (AVO) is tardy in releasing very bad news but eventually fesses up. But it misleads investors. Its (now very clearly former) partner Sinophi then, effectively, accuses it of lying. Oh dear, for the second time Sinophi has stated that (almost insolvent) Advanced is telling porkies.

Bearcast

Tom Winnifrith Bearcast: Corporate lying & using the wrong words: I am sounding like my father

If I sound more like my father that is a good thing for he is honest and precise in his use of language, although he would not use some of the "french phrases" which occur in this podcast. I discuss the use of language and how wording has an exact meaning - this is in relation to Coral Products (CRU) which needs to clarify something. I do not think it is a fraud and it can easily blame its useless Nomad Cairn. After what it has signed off for Cloudtag (CTAG) few will fail to accept such an excuse. I then move onto deliberate lying by AIM Companies which is actually quite rare. Gross over-promotion is quite common. I explain the difference. Cloudtag and Advanced Oncotherapy (AVO) are mentioned in detail in this section. In discussing what is a fact I refer to my article of yesterday on Holocaust Memorial Day which is HERE

AVO
AVO

Advanced Oncotherapy - Report back from Proactive ramp session: the Maths of Doom

I had a couple of contacts attending Thursday's attempted rampfest by floundering Advanced Oncotherapy (AVO) hosted (for a fee) by the sleazy IR promoters at Proactive Investors. I am grateful to one financial analyst - who is short of the stock - for his notes.

Bearcast

Tom Winnifrith Bearcast: The great director share buying spoof, oh Joe you are such a naughty boy

You think that following director share buys is smart? Not always. I start with Coral Products where old Joe Grimond really is spoofing us all with a recycling of a dividend that really should not be paid. Coral also highlights those scallywags at Cairn signing off on another RNS lie just like they do for the fraud  Cloudtag (CTAG). Then I look at Quindell (QPP) in that vein and at Avanti Communications (AVN) commenting on its refinancing completed today. Then it is onto the hot gossip of the cash crisis at Advanced Oncotherapy (AVO) where I have another story breaking this weekend. Finally I touch on the troubles at Guscio (GUSC)

Bearcast

Tom Winnifrith Bearcast: Explaining exactly why Cloudtag is not a bad company it is a FRAUD

Apparently some folks think that Cloudtag (CTAG) is just a bad company not a fraud. I explain to such folks the difference between a fact and an opinion (Latin scholars are aware of this already) and why exactly that makes this company a 100% fraud. Its shares are now just 4.75p to sell but the target remains 0p as it is a fraud. Then it is on to the importance of NEDS and what they are there for ref Advanced Oncotherapy (AVO). Then I move to Ashley House (ASH) and a bit of macroeconomics, to Grand Group (GIPO) and onto Galantas Gold (GAL)

AVO
AVO

Advanced Oncotherapy: GOTCHA again - another NED walks as predicted here

On December 2 2016 I suggested here that Advanced Oncotherapy NED Tim Lebus had had enough and was walking. The lying snot-gobblers round at Advanced declined to comment. Guess what? He has walked with immediate effect today. It gets better, if you are a bear.

Bearcast

Tom Winnifrith Bearcast: Winnileaks vindicated in spades today..whatever criminal Aidan says

Criminal Aidan Earley says thatmy work destroys great British Companies. That is what Rob Terry used to say too. What is the difference between those two fraudsters? About £50 million and so far only one has served time. I discuss Winnileaks triumphs today on Advanced Oncotherapy (AVO) and Strat Aero (AERO) and why they vindicated my work so much. Then I look at BT (BT.A), Rosslyn Data (RDT), Cloudtag (CTAG), Sunrise Resources (SRES) and LGO Energy (LGO).   

AVO
AVO

Sinophi walks , Disingenuous Advanced Oncotherapy is fucked - insolvency beckons

Yesterday I goaded AIM weasels Advanced Oncotherapy (AVO) to come clean on the status of its relationship with Chinese distributor Sinophi, HERE. It seems the world moves quickly because Advanced has today announced that Sinophi has, as of yesterday, "terminated" its orders and at a stroke the order book goes from $150 million to nil. But this smells all wrong and at the same time means that Advanced may well go bust within five weeks. Let me explain.

AVO
AVO

Advanced Oncotherapy says still talking to funders - will it be insolvent in five weeks?

Advanced Oncotherapy (AVO) said in September that it would secure additional non dilutive funding by the year end. Today it is clarified where it stands but has neglected to point out how perilous its financial position is. Net current assets will be negative within five weeks which begs a real question regarding whether this company is solvent

Bearcast

Tom Winnifrith Bearcast: possibly the biggest scandal in AIM history to go nuclear this week?

Weekend press reports (not in the UK natch as the British press is ignoring this £2 billion City scandal for reasons one can only imagine) suggest that the FBI is now investigating. Already in France there have been arrests including that of the CEO of Areva - Atomic Anne - which bought AIM & TSX listed Uramin for £2 billion and had written all of its assets off as worthless within three years. There is also a major new investigative book out on the scandal due out on Thursday. I am sure my good friend Jim Mellon will be ordering an advance copy. Elsewhere I look at Vislink (VLK), at the train wreck waiting to happen at Advanced Oncotherapy (AVO), at Fitbug (FITB) and Cloudtag (CTAG) and then finally at SalvarX (SALV) - placing ahoy on this related party express train to planet hype.

AVO
AVO

Advanced Oncotherapy - where is that new funding you promised brokers would arrive by December 31?

AIM (very) bad boy Advanced Oncotherapy (AVO) did its best to ramp its shares following the shock loss of its entire order book back in November. Or was it October? Glitzy promo videos and spoofing share purchases by NEDs phased out to have maximum effect on fooling the gullible managed to get the shares back to c90p. But now folks are looking behind the smokescreen of bullshit and the shares are tumbling again, to 73.5p. Since this company has committed securities fraud my target remains 0p. The questions are mounting fast.

Bearcast

Tom Winnifrith Bearcast - News from the Inspirit Boiler room is bad but Advanced Onco's bad news is er?

I start with thanks for all the offers of support in dealing with the criminal poltroon Aidan Earley of Worthington (WRN)  - now in liquidation - infamy. I then look at Advanced Oncotherapy (AVO) and the questions it is NOT answering. Then I touch on Audioboom (BOOM) before going onto Parallel Media (PAA) before ending up with the basket case that is Inspirit Energy(INSP), its bleak future and its links to the Teathers Financial (TEA) scandal. Finally I brace myself for a night of woe tomorrow.

Bearcast

2016 a bearcast year in review: Tom Winnifrith's favourite 10, and your top thirty

When I started bearcasts the plan was not to do them on a daily basis. But that is the way they are now produced. I have the odd day off but I enjoy recording. You cannot generate a typo in a bearcast. Sometimes the language is extreme, sometimes - as when, like now, I am with my father, - I speak like an Angel. The point is I say what I think and for some reason, most weeks, the bearcasts are always among the most read articles on ShareProphets.

Crime-Scene

A year of fraudbusting by ShareProphets reviewed - what a bumper crop we had in 2016

Some of our critics, notably the felon Earley, reckon we go after companies as part of some convoluted con whether those companies are good or bad. Those who actually read our site will know that very few of the companies we have attacked have been anything other than disasters for investors. The one we got wrong and admitted as much was Boohoo. But boy did we make some gutsy calls in 2016 - we had a bumper year of fraud busting.

REM
REM

REVIEWED: ShareProphets writers share tips of the year for 2016

On the long tack, it is congratulations to Gary Newman with Vedanta Resources (VED, currently +220%) edging out Steve Moore (Avesco Group, +186%)...

AVO
AVO

Advanced Oncotherapy - even house broker Beaufort now getting cold feet

As joint house broker to the exponent of Securities fraud that is Advanced Oncotherapy (AVO), Beaufort has to sound bullish and has thus reiterated its speculative buy stance today. But read the note carefully. Beaufort is frit. I have highlighted key phrases that have not appeared before for you. Key phrases which show goalposts being moved and a broker that is sick of being made to look foolish.

AVO
AVO

Advanced Oncotherapy: the answer to evidence you committed securities fraud is not a sham video

It is now 11 days since I published details of leaked emails which showed that AIM scumbag Advanced Oncotherapy had withheld awful trading news from investors as the company launched an open offer. That is clearly securities fraud. Almost as bad, the emails showed that the timelines the company had held out to both customers in China and investors in London for product delivery were just fantasy. And that is why customers walked. Heads should have rolled. Hapless Nomad Stockdale should have forced a statement. And having told its house broker (Beaufort) that a much needed refinancing would happen by the year end, we need an update on that too. Instead...

Bearcast

Tom Winnifrith Bearcast - the A to E of AIM fraud. Guess what C is for?

In today's bearcast I look at the A to E of AIM fraud. It covers Advanced Oncotherapy (AVO), Boxhill (BOX, Cloudtag (CTAG), Daniel Stewart (DAN) and Eden Research (EDEN). Can you remember which two of those have sent me a fascist lawyer's letter?

Newsboy

Notes from Underground: Human sacrifice, dogs and cats living together... mass hysteria

Well, well, well. The Cloudtag (#CTAG) saga has not just whipsawed through the wallets of slackjawed investors, it has upturned this weekly feature. A feature, for the first time since the creation of this list, has made it to #4 without being written by Tom Winnifrith. Behold Is CloudTag sitting on a price-sensitive conversion notice? by Cynical Bear.

New Bulletin Board Moron of the Week Contest sponsored by sleazy Lord Peter Hain

I shall be saying another prayer at the little church on the way to my Greek Hovel tomorrow morning. It will be a prayer asking God not only to show strength to my source on the kerboom emails for one AIM stock but also to make Lord Peter Hain see the light about his involvement with the fraud African Potash (AFPO) as it prepares to see its shares suspended this Wednesday. Lord Hain is no doubt familiar with the book of Mark, chapter 10 verses 20-24. King James version natch:

AVO
AVO

Advanced Oncotherapy - now tell us about the additional financing you promised by the year end?

Time is running out for Advanced Oncotherapy (AVO) as it scrabbles for additional finance but this time it really needs to start telling the truth to potential backers. In fact before I reveal more leaked emails I invite it to correct some previous lies told now.

AVO
AVO

Don't Kick Yourself Over Advanced Oncotherapy - Nor Let It Put You Off Other Medical Ventures

Hello Share Shiners. The decaying share value of Advanced Oncotherapy (AVO) after and during inquiries by Uncle Tom will have left a fair few of us nursing losses. My own shortfall after selling my shares is not to be sniffed at.

Bearcast

Tom Winnifrith Bearcast: Insanity, Insanity and yet more Insanity

My day at the olive harvest was tiring and curtailed only slightly by Vreki - details HERE. But that explains the late bearcast on a day of stockmarket insanity. I discuss Santa rallies and some true indicators of the lunacy that abounds. At a company level I comment on Cloudtag (CTAG), Servision (SEV), African Potash (AFPO), Advanced Oncotherapy (Hee Hee), Metal Tiger (MTR), Amur Minerals (AMC) and Strat Aero (AERO).

AVO
AVO

Advanced Oncotherapy - The deafening silence is itself a cause of panic: target price is 0p

Yesterday I published extracts from leaked emails that show that Advanced Oncotherapy (AVO ) kept very bad news regarding China contracts from investors as it launched and conducted an open offer. That is monumentally serious. In the US folks would already be doing a perp walk fort that but even our useless regulators will do something here. In normal circumstances the company would issue a response via RNS but here we are a day and a half later and even though the shares slumped yesterday and are sliding again today we hear only a deafening silence.

Bearcast

Tom Winnifrith bearcast: Don't the fecking Cloudtag morons know I'm harvesting olives?

I am utterly shattered after day three of the olive harvest - a photo article is HERE. Please note Cloudtag (CTAG) morons I can't respond to your inane tweets at once every day. Cloudtag shares have raced ahead today. I explain why and why it won't last. As with all frauds the target price is 0p. Talking of which I also discuss Advanced Oncotherapy (AVO) which seems unwilling to comment on today's bombshell revalations and African Potash (TOAST). I also look at Mirada (MIRA), Interquest (ITQ) and Aeorema Communications (AEO)

AVO
AVO

Explosive email leak - Advanced Oncotherapy and Sinophi: the real timeline emerges

AIM promote Advanced Oncotherapy (AVO) and Sinophi have already publicly disagreed as to whether the $120 million order by the Chinese has been "terminated" or not and and on when it was "terminated". Advanced announced the bad news on November 24 suggesting no termination, Sinophi used the T word and said it told Advanced in "early November". A source out East has ensured that I have now obtained access to confidential emails from Sinophi to Advanced which show that Advanced was aware of problems far earlier and at a time when it was soliciting funds from investors. It did not tell those investors. Heads must roll.

Newsboy

Notes from Underground: Popcorn time

Well, it's time to sit back, put one's feet up, and watch how the Cloudtag events unfold. Will the company avoid the terrible fate of the death spiral? Or will it, as the bulletin board morons suggest, suddenly demonstrate a viable and desirable wearable product at the CES 2017 trade fair in, oh, five weeks.

Bearcast

Tom Winnifrith Bearcast: 550kg of olives harvested in one day, I'm cream crackered

I am utterly wiped out after day one of what looks like being a cracking harvest. A full photo report is HERE. In the podcast I discuss votes tomorrow in Austria and Italy and what they mean and why we bears are feeling good about the lack of a Santa Rally. Trump was Santa this year and that rally is over. I explain why I disagree with Malcolm Stacey's article today. I then look at a number of AIM stocks set to slide and why, as I refer to Steve's piece earlier. In focus: Avanti Communications (AVN), Advanced Oncotherapy (AVO), Telit (TCM), Boohoo (BOO), Tungsten (TUNG), Fastjet (FJET), Cloudtag (CTAG), African Potash (AFPO) and I have a few words about Worthington (WRN)

AVO
AVO

Advanced Oncotherapy - now about Tim Lebus

Tim Lebus is a non executive director at Advanced Oncotherapy (AVO). Well sort of.

Bearcast

Tom Winnifrith Bearcast: Speaking at length about AIM fraud to a bird from Bloomberg

She was horrified. I am not sure she agreed with my line that the mainstream press were part of the problem not the solution but she agreed that AIM had its issues. On the bearcast today I look at Red Leopard (RLH), Formation Group (FRM), Mobile Streams (MOS) and its charming CEO - Andalas (ADL) - whose CEO is a tosser - Strat Aero (AERO), Finnaust (FAM), Inspirit (INSP), Plus 500 (PLUS), Advanced Oncotherapy (AVO)), TrakM8 (TRAK) and Cloudtag (CTAG) plus one way of looking at it which sees 300 companies on AIM as a sort of fraud.

AVO
AVO

Advanced Oncotherapy - Sinophi denial throws up more red flags: this stinks more and more

In the face of relentless pressure from this website, embattled Advanced Oncotherapy (AVO) yesterday put out a statement attempting to draw a line in the sand over its falling out with Sinophi, whom it had claimed was set to buy $120 million of machines from it. It has failed. the statement begs even more questions and the shares remain utterly uninvestable.

Bearcast

Tom Winnifrith Bearcast: the storm clouds cover the mountains where the Greek Hovel lies

Though I may have pneumonia thanks to Paul Scott, I am now safely in Kalamata looking up at the mountains where I live when in Greece and the storm clouds are ominous. So back to the stockmarket I look at Finnaust (FAM), Audioboom (BOOM), Avanti Communications (TOAST), Condor Gold (CNR), Advanced Oncotherapy (AVO), Webis (WEB) and Anglesey Mining (AYM) which is spouting bullshit today as it places.

Bearcast

Tom Winnifrith Bearcast: Is Mosman Oil & Gas the worst run shitty little AIM oil company?

I must rush. Woodlarks beckons and then it is Greece. But first I look at: Advanced Oncotherapy (AVO) in light of last night's bombshell HERE, TrakM8 (TRAK ) - chatting to Paul Scott - Pantheon Resources (PANR), Bushveld Minerals (BMN), FastForward (FFWD), Jim Mellon's reported comments and Mosman oil & Gas (MSMN).

AVO
AVO

Kerboom! Gotcha! Sinophi statement up throws massive spanner in Advanced Oncotherapy works - Timber!

Advanced Oncotherapy's (AVO) much ramped JV with China based Sinophi is falling apart in the most embarrassing of ways. Advanced announced its first deal with Sinophi on March 25 2015, a statement made by Sinophi should have the FCA and AIM regulation crawling all over this one.

Bearcast

Tom Winnifrith Bearcast: Justin the Clown might upgrade from his cardboard box home in time for Christmas

In this bearcast I start with yesterday's party with my wife's colleagues, the Guardian reading sociology lecturers. I was biting my lip hard. Then it is onto Trakm8 (TRAK) and a general point about acquisitive companies - the specifics of my latest triumph are covered HERE. Then it is onto Cloudtag (CTAG) and a detailed look at the numbers for Advanced Oncotherapy (AVO) in terms of when it will run out cash, then onto Boxhill (BOX) and more questions for sleazy Lord Razzall. I then cover Premier Oil (PMO) and the stock that left podcasting share ramper Justin the Clown living in a cardboard box, Andalas Energy (ADL)

Bearcast

Tom Winnifrith Bearcast: reading the Bulletin Boards to apply the Tom Winnifrith test

I have spent the morning reading a few Bulletin Boards. I feel dirty in admitting to doing this as it is something I do very rarely and only when no-one is watching. Specifically I looked at threads on Cloudtag (CTAG), Strat Aero (AERO) and Advanced Oncotherapy (AVO) for instructive lessons in both human behaviour and also the nature of all the best frauds.

AVO
AVO

Letter to AIM Regulation & FCA re Advanced Oncotherapy - URGENT enquiry needed now

Yesterday shares in Advanced Oncotherapy (AVO) plunged after it fessed up that a critical deal worth up to $120 million with a Chinese entity had encountered problems. Those who backed a big fundraise just weeks ago are already 26% down. But the incident begs massive questions about the timeline of disclosure and RNS statements that appear to be utterly untrue. I have written to the FCA & AIM Regulation, as this appears to be market abuse, outlining my very specific concerns and demanding an urgent enquiry and, if appropriate, that sanction be taken against those responsible. The letter is below:

AVO
AVO

Why I've Sold All My Advanced Oncotherapy Shares.

Hello Share Mongers. About two years ago I suggested you take a look at Advanced Oncotherapy (AVO). I was glad I did as I seem to recall that the shares rose from about 3p at the time to around 18p. 

Bearcast

Tom Winnifrith Bearcast: Red Flags come home to roost for the Sheriff's fave AIM Turkeys

How is that for a Thanksgiving mixed metaphor of a title? In this podcast I look at denial, red flags and bending the rules on the Casino. Among the companies covered today are:  Advanced Oncotherapy (AVO), Cloudtag (CTAG), African Potash (AFPO), Fastjet (FJET) and the insider dealing, Mkango Resources (MKA), London Capital (LCG), Audioboom (BOOM), Milestone Group (MSG) and I flag up that Steve & I have a hot share tip you can access for just £5 coming up very soon HERE

AVO
AVO

Advanced Oncotherapy - so does it have any orders at all? What does it define as a sale? This stinks

How many commercial orders does Advanced Oncotherapy (AVO) have for its Proton beam machines? I put it to you that the answer is zero but that it has always been zero. This company appears to have over-egged the pudding on a serial basis, allowing it to raise vast sums. The FCA should be now launching an urgent investigation into this matter demanding to see original "commercial sales" paperwork in order to see if Advanced has been as transparent as the rules dictate.

AVO
AVO

Sunday Times on Proton Beam Therapy - the numbers for Advanced Oncotherapy do not add up

The Sunday Times today has splashed on the roll out of proton beam therapy centres in the UK. It states there are plans to build SIX centres in the UK...but....

AVO
AVO

Gotcha! Tony Blair crony Labour Lord David Evans goes at Advanced Oncotherapy "with immediate effect" - 6 days after I reveal share dealing scandal

There is no explanation at all given for today's resignation, with immediate effect, of Lord David Evans from the board of Advanced Oncotherapy (AVO). If it had been planned, as a result of illness or some other matter, it would have been announced with other board changes on October 10 and 27. Make no mistake: the reason that Evans has "resigned" is my scoop of 6 days ago regarding his share dealings - Congratulations you Blairite low life you have met The Sheriff of AIM.

AVO
AVO

Open Letter: Marcus Stuttard, Mr Bogus Sheriff of AIM - are Lords exempt from your rulebook?

Earlier today I pointed out how Lord David Evans, the senior NED at Advanced Oncotherapy (AVO) sold his entire holding of shares during a closed period and just ahead of a major placing. He appears only to have told the company this week, although the share sales took place between 19 August 2016 and 16 September 2016. This is a massive breach of AIM Rule 21. I have written to Marcus Stuttard, the head of the Oxymorons at AIM Regulation.

AVO
AVO

Advanced Oncotherapy, Lord David Evans and that pre-placing share dumping - why no P45?

On 30 September 2016 Advanced Oncotherapy (AVO) announced not only its interim results but also a large placing at 100p. In the run-up to a placing and in the eight week closed period ahead of numbers surely no director could dump his entire holding? Surely not? Think again.

AVO
AVO

Advanced Oncotherapy Open Offer at 100p: I'd rather get stranded on a desert Island with Hillary Clinton than accept

As indicated at the time of its bailout £10 million placing on September 30th, Advanced Oncotherapy (AVO) has now announced that it is to raise up to £4.8 million via an open offer at 100p. With the shares at 102p to sell, I'd rather sign up to spend two weeks alone on a desert island with crooked Hillary droning on about how being a rape enabler makes her a good feminist, than accept this offer.

Newsboy

Notes From Underground: Giving thanks

Dear reader, it's one of the most important holidays on the calendar today, Thanksgiving. The real one. The Canadian one. Oh sure, next month we'll hear all about the US holiday and where to buy turkey and it's related treats, but remember who did it first.

Bearcast

Tom Winnifrith Bearcast: 100% Shite Research from Belfort Securities on Advanced Oncotherapy, Servision and Strat Aero

I am in a bad mood because a) baby with no name is screaming a lot and I am tired and b) some little shit for brains round at Beaufort Securities was slagging me off to a client today. This little turd of little brain turned out to have his facts wrong and so I am now officially on the warpath and, hence, go through today's morning note from Belfort and dissect its utterly 100% shite research on Strat Aero (AERO), Advanced Oncotherapy (AVO) and Servision (SEV). I also look at Audioboom (BOOM) and Kodal Minerals (KOD).

AVO
AVO

Advanced Oncotherapy - Placing next week? Will it start to be honest about how small its potential market is?

Advanced Oncotherapy (AVO) announced its interim results on 22nd September 2015 and so you would expect that it will be publishing numbers for 2016 within the next week or so. The main question is whether it will be accompanied by a desperately needed placing of at last £35 million? But as we await that I wonder if the company would care to update us all on the true state of its UK sales pipeline. Telling the truth is not too much to ask is it?

Bearcast

Tom Winnifrith Bearcast: how the Press mugs investors - ref Lombard Risk & Advanced Oncotherapy

In this podcast I refer to my non financial podcast today on the great Olympic Con - sport is not making Britain Great again (HERE) and also to part 4 of the new series: The Chairman's Blog by Sir Benjamin Dover HERE. Then I go onto how the corrupt financial press and PR flunkies use and abuse you as readers and investors with special reference to bank closures and Lombard Risk Management (LRM)  in the Mail on Sunday and, especially, Advanced Oncotherapy (AVO) in today's Sunday Times.

Bearcast

Tom Winnifrith Bearcast - Avanti won't be playing Germany in the invasion of France role play

I am challenged to comment on Cenkos (CNKS) as an investment in light of todays news on its role in the Quindell fraud (HERE). Okay, I do my best. Then it is on to Techfinancials (TECH), Advanced Oncotherapy (AVO) and some friendly advice for Malcolm Stacey, Gulf Keystone (GKP), XCite Energy (XEL) and then I end with Avanti Communications (AVN) where I hope you understand the historical analogy.

Bearcast

Tom Winnifrith Bearcast - looking back to 2001 and forward to 5PM today

I start by looking at the collapse of Crowdmix and how it so remoinds me of 2001 and what is says about the tech bubble, someting that is very much on my mind right now, as you can see HERE. Then I look forward to tomorrow in Shipston but more imprtantly to the demise, later today, of Worthington (WRN). I cover Ariana Resources (AAU) where I am cross and puzzled, Advanced Oncotherapy (AVO) - how is the placing going Belfort? - Weatherley (WTI) and Ferrum Crescent (FCR)

Bearcast

Tom Winnifrith Bearcast: Highland Natural at 19p, fair value 3p

A few words on logistics then after today's debacle at Highlands Natural Resources (HNR) I explain why the shares are worth just 3p (or less). Then it is onto PCG Entertainment (PGCE), Jiasen (JSI), Belfort Securities and its morality vacuum, Tungsten (TUNG), Onzima (ONZ), IGAS (IGAS) and Solo (SOLO). Finally, more than a few words about Advanced Oncotherapy (AVO)

Bearcast

Tom Winnifrith Bearcast - Gooseberry Crumble, Avanti crumbles

I have spent the morning getting twitter grief for this article but the one polite twitter enquiry concerns BoxHill (BOX) and I answer that in this podcast as well as explaining why shares are both up and down since Brexit - it all depends how you look at it. I also cover Gulf Keystone (GKP), Bluebird Merchant Ventures (BMV), Advanced Oncotherapy (AVO) and Avanti Communications (AVN), I meant to talk about Bovis (BVS) but forgot. I shall try to remember tomorrow when I am down to make a gooseberry crumble. I shall report back on that over the weekend.

GetAFix

Malcolm Stacey on holiday Caption Contest day 6 & day 5 winner

Yesterday's holiday snap from Getafix generated 17 possible captions. The most innacurate, from Backwoodsman, suggested that Malcolm burying his cash in the ground might be his worst investment decision. No way. Surely buying LGO shares was worse. At least there is a slim chance of getting your cash back out of the hole. But Backwoodsman also served up the winner. You can see all 17 entries HERE. Today Malcolm's snap suggests the old rogue has got very lucky. Do your worst.

GetAFix

Malcolm Stacey on Holiday Caption Contest day 3 (and day 2 winner)

Getafix is still on holiday and without his enthusiastic endorsement trading activity in Advanced Oncotherapy (AVO) has all but disappeared. But as a consolation the old boy has sent us another holiday snap which is begging for a suitable caption. Yesterday's picture produced a standout winner from the 10 entries as you can see HERE

GetAFix

Malcolm Stacey Goes on Holiday - caption Contest One

Old Getafix feels that he needs a break and so, cashing in a few of his dividend cheques, he has ,left us for a week but is sending back pictures every day for the Malcolm Stacey daily caption contest. Simply post your entries in the comments section below with a deadline of midnight. I shall start the ball rolling with this entry:

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|